| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/08/2001 | WO2001016312A2 Nucleic acid based modulators of gene expression |
| 03/08/2001 | WO2001016306A2 Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
| 03/08/2001 | WO2001016301A1 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 03/08/2001 | WO2001016299A1 Use of dna encoding osteoprotegerin to prevent or inhibit metabolic bone disorders |
| 03/08/2001 | WO2001016297A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | WO2001016293A2 Dna encoding the human serine protease t |
| 03/08/2001 | WO2001016288A2 Dna encoding the human serine protease c-e |
| 03/08/2001 | WO2001016175A1 A novel human rab gene and its coding polypeptide |
| 03/08/2001 | WO2001016173A1 fabF |
| 03/08/2001 | WO2001016171A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016169A2 RET LIGAND 5 (Retl5) FROM HUMAN AND MOUSE |
| 03/08/2001 | WO2001016168A2 Induction of programmed cell death by n5 gene |
| 03/08/2001 | WO2001016167A2 Beta-catenin, tcf-4, and apc interact to prevent cancer |
| 03/08/2001 | WO2001016165A2 Apoptin-associating protein |
| 03/08/2001 | WO2001016156A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | WO2001016106A1 Benzamide formulation with histone deacetylase inhibitor activity |
| 03/08/2001 | WO2001015755A2 Methods and compositions for delivery of pharmaceutical agents |
| 03/08/2001 | WO2001015740A1 Single-stranded oligodeoxynucleotide mutational vectors |
| 03/08/2001 | WO2001015737A2 Method for coupling molecules |
| 03/08/2001 | WO2001015709A1 USE OF rAFP TO INHIBIT OR PREVENT APOPTOSIS |
| 03/08/2001 | WO2001015676A2 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | WO2001015531A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 03/08/2001 | WO2001015511A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 03/08/2001 | WO2000066735A3 Human ion channel proteins |
| 03/08/2001 | WO2000061624A8 48 human secreted proteins |
| 03/08/2001 | WO2000058475A3 Streptococcus pneumoniae antigens |
| 03/08/2001 | WO2000018961A3 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 03/08/2001 | DE19940012A1 Eukaryotic expression plasmid useful for treating peripheral arterial occlusive disease, comprises two expression cassettes, one containing the gene for human vascular endothelial growth factor VEGF165 |
| 03/08/2001 | CA2403243A1 Nucleic acid based modulators of gene expression |
| 03/08/2001 | CA2387291A1 Dna encoding the human serine protease t |
| 03/08/2001 | CA2384026A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | CA2383910A1 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 03/08/2001 | CA2383877A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | CA2383784A1 Apoptin-associating protein |
| 03/08/2001 | CA2383693A1 Card proteins involved in cell death regulation |
| 03/08/2001 | CA2383606A1 Iren protein, its preparation and use |
| 03/08/2001 | CA2383519A1 Antibody dependent enhancement (ade) of alphavirus infection |
| 03/08/2001 | CA2383411A1 Hepatitis c virus replication inhibitors |
| 03/08/2001 | CA2383367A1 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
| 03/08/2001 | CA2383358A1 Methods and compositions of a novel serine protease inhibitor |
| 03/08/2001 | CA2383043A1 Use of dna encoding osteoprotegerin to prevent or inhibit metabolic bone disorders |
| 03/08/2001 | CA2382953A1 Dna encoding the human serine protease c-e |
| 03/08/2001 | CA2382952A1 Induction of programmed cell death by n5 gene |
| 03/08/2001 | CA2382622A1 Polycyclic aromatic hydrocarbon induced molecules |
| 03/08/2001 | CA2382562A1 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | CA2382499A1 Method for coupling molecules |
| 03/08/2001 | CA2382303A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 03/08/2001 | CA2382120A1 Single-stranded oligodeoxynucleotide mutational vectors |
| 03/08/2001 | CA2382030A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | CA2381451A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | CA2348158A1 Modified adenoviral fibre and uses thereof |
| 03/08/2001 | CA2303504A1 Diagnostic methods in autoimmune disease |
| 03/07/2001 | EP1081227A1 Methods and means for retroviral gene delivery |
| 03/07/2001 | EP1081226A1 Apoptin-associating protein |
| 03/07/2001 | EP1080733A1 Solid preparations for oral administration of drugs relating to genes |
| 03/07/2001 | EP1080370A1 Identification of broadly reactive dr restricted epitopes |
| 03/07/2001 | EP1080233A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products |
| 03/07/2001 | EP1080226A1 Compositions and methods for topical delivery of oligonucleotides |
| 03/07/2001 | EP1080225A1 Compositions and methods for the pulmonary delivery of nucleic acids |
| 03/07/2001 | EP1080217A1 Recombinant cytomegalovirus expression system targeting the immediate-early gene region |
| 03/07/2001 | EP1080216A2 Retroviral delivery system |
| 03/07/2001 | EP1080215A1 Mutant herpes simplex viruses and uses thereof |
| 03/07/2001 | EP1080206A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiqitous endoproteases |
| 03/07/2001 | EP1080202A2 Convection-enhanced delivery of aav vectors |
| 03/07/2001 | EP1080199A2 (hemorrhagic enteritis) virus dna sequences, proteins encoded thereby and various uses thereof |
| 03/07/2001 | EP1080195A1 Endometriosis-associated gene |
| 03/07/2001 | EP1080186A2 Method for altering the activity of proteins of the pka signaling pathway |
| 03/07/2001 | EP1080181A1 clpX OF STREPTOCOCCUS PNEUMONIAE |
| 03/07/2001 | EP1080110A2 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system |
| 03/07/2001 | EP1080108A1 Cytokine resistant cytomegalovirus promoter mutants and related products and methods |
| 03/07/2001 | EP1080106A1 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080103A1 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 03/07/2001 | EP1080100A1 Cytosine deaminase gene |
| 03/07/2001 | EP1079864A1 Materials and methods for delivery and expression of heterologous dna in vertebrate cells |
| 03/07/2001 | EP1079854A1 Compositions and methods of modulating an immune response to an antigen |
| 03/07/2001 | EP1079844A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1 |
| 03/07/2001 | EP1079807A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract |
| 03/07/2001 | EP1079806A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear |
| 03/07/2001 | EP0918874B1 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
| 03/07/2001 | CN1286727A Neisserial antigens |
| 03/07/2001 | CN1286726A Histamine and serotonin binding molecules |
| 03/07/2001 | CN1286630A Targeted liposome gene delivery |
| 03/07/2001 | CN1286263A Human Rab gene and polypeptide coded with it |
| 03/06/2001 | US6197944 DNA molecules stabilized by modifications of the 3′-terminal phosphodiester linkage |
| 03/06/2001 | US6197931 Human marco scavenger receptor |
| 03/06/2001 | US6197925 NF-AT polypeptides and polynucleotides |
| 03/06/2001 | US6197756 Transferring transgene dna sequence |
| 03/06/2001 | US6197755 Compositions and methods for delivery of genetic material |
| 03/06/2001 | US6197754 Tyrosine kinase inhibitor |
| 03/06/2001 | US6197584 Antisense modulation of CD40 expression |
| 03/06/2001 | US6197581 Human adenylate cyclase and use therefor |
| 03/06/2001 | US6197580 Transcriptional regulation of the human β3-adrenergic receptor gene |
| 03/06/2001 | US6197578 Cells expressing both human CD4 and a human fusion accessory factor associated with HIV infection |
| 03/06/2001 | US6197546 PcrA Helicase of Staphylococcus aureus |
| 03/06/2001 | US6197525 Kit for detection of interleukin-17, interleukin-17 receptor, antagonists, or mimetics; includes receptor protein of defined amino acid sequence and a detecting reagent; for identifying immunosuppressants |
| 03/06/2001 | US6197521 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 03/06/2001 | US6197519 Pancreas-derived serpin |
| 03/06/2001 | US6197332 Lipid-conjugated polyamide compounds and related compositions and methods thereof |
| 03/06/2001 | US6197300 ftsZ |